Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings
BNGO·Reported August 7, 2024·After market close
Bionano Genomics, Inc. reported Q2 2024 revenue of $7.8M, beat analyst consensus of $6.3M by $1.5M. Diluted EPS came in at $-14.37, missed the $-0.42 consensus by $13.95.
Revenue
$7.8Mbeat by $1.5M
Consensus: $6.3MDiluted EPS
$-14.37missed by $13.95
Consensus: $-0.42
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Bionano Genomics, Inc.'s Q2 2024 earnings report.
Bionano Genomics, Inc. (BNGO) reported Q2 2024 earnings on August 7, 2024 after market close.
Bionano Genomics, Inc. reported revenue of $7.8M and diluted EPS of $-14.37 for Q2 2024.
Revenue beat the consensus estimate of $6.3M by $1.5M. EPS missed the consensus estimate of $-0.42 by $13.95.
You can read the 10-Q periodic report (0001411690-24-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.